DH Private Equity Partners:企業の戦略・SWOT・財務分析

◆英語タイトル:DH Private Equity Partners - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4052
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DH Private Equity Partners – Strategy, SWOT and Corporate Finance Report
Summary

DH Private Equity Partners – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DH Private Equity Partners (DH) is a private equity company. The company makes investments in private equity, real estate, and technology ventures portfolios. It provides support services in the area of investment strategy, portfolio management, investment advisory and consultancy, operational developments, strategic expansion, and value enhancement. It acquires and invests in mid-market businesses and leveraged buyouts and buy-ins. DH operates through a network of offices and has developed a strong relationship with the advisors and owners of industrial operations and businesses in Europe. The company’s investment portfolio includes investment in diversified geographies including North America, the UK, Middle East, Asia Pacific, and Europe region. DH is headquartered in London, the UK.

Scope

- Detailed information on DH Private Equity Partners required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DH Private Equity Partners in the form of a SWOT analysis
- An in-depth view of the business model of DH Private Equity Partners including a breakdown and examination of key business segments
- Intelligence on DH Private Equity Partners’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DH Private Equity Partners, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DH Private Equity Partners and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DH Private Equity Partners as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DH Private Equity Partners’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
DH Private Equity Partners: Company Overview
DH Private Equity Partners: Overview and Key Facts
DH Private Equity Partners: Overview
DH Private Equity Partners: Key Facts
DH Private Equity Partners: Key Employees
DH Private Equity Partners: Key Employee Biographies
DH Private Equity Partners: Major Products and Services
DH Private Equity Partners: Company History
DH Private Equity Partners: Key Competitors
DH Private Equity Partners: Company Analysis
DH Private Equity Partners: Business Description
DH Private Equity Partners: SWOT Analysis
DH Private Equity Partners: SWOT Overview
DH Private Equity Partners: Strengths
DH Private Equity Partners: Weaknesses
DH Private Equity Partners: Opportunities
DH Private Equity Partners: Threats
DH Private Equity Partners: Corporate Financial Deals Activity
DH Private Equity Partners: Financial Deals Overview
DH Private Equity Partners: Top Deals 2016 – 2020YTD*
DH Private Equity Partners: Advisors
DH Private Equity Partners: Top Legal Advisors
DH Private Equity Partners: Divestments
DH Private Equity Partners: Recent Developments
DH Private Equity Partners: News and Events Summary
DH Private Equity Partners: Financial Performance
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: DH Private Equity Partners: Key Facts
Table 2: DH Private Equity Partners: Key Employees
Table 3: DH Private Equity Partners: Company History
Table 4: DH Private Equity Partners: Key Competitors
Table 5: DH Private Equity Partners: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 6: DH Private Equity Partners: Top Deals 2016 - 2020YTD*
Table 7: DH Private Equity Partners: Legal Advisor Ranking by Value (US$m)
Table 8: DH Private Equity Partners: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 9: DH Private Equity Partners: Divestments by Geography (2016 - YTD*2020)
Table 10: DH Private Equity Partners: News and Events Summary
Table 11: DH Private Equity Partners: Financial Performance

★海外企業調査レポート[DH Private Equity Partners:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • JSC Inter RAO:企業のM&A・事業提携・投資動向
    JSC Inter RAO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSC Inter RAO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Endonovo Therapeutics Inc (ENDV):製薬・医療:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Zhifei Biological Products Co Ltd (Zhifei) is a vaccine manufacturer. The company offers HibACon, MeningACon, menwayc, mycobacterium vaccae, haemophilus influenzae type b conjugate vaccine and hepatitis A (live) vaccine, freeze-dried. It research, develops, produces and markets vac …
  • Green Cross Cell Corp (031390):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of co …
  • Personal Group Holdings Plc:企業の戦略・SWOT・財務情報
    Personal Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Personal Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SymBio Pharmaceuticals Ltd (4582):企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • IGas Energy PLC (IGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary IGas Energy PLC (IGas) is an oil and gas company that explores, develops and produces onshore oil and natural gas properties. The company extracts oil and gas trapped underground in basins. It develops and produces gas and oil reserves in the North West of England, the East Midlands, the Wea …
  • Ezra Holdings Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Ezra Holdings Limited (Ezra Holdings) is an offshore contractor and provider of integrated offshore solutions to the oil and gas industry. The group's service portfolio consists of subsea construction and maintenance, drilling support, towing and mooring, pipe and cable operations, high spee …
  • Bata India Limited
    Bata India Limited - Strategy, SWOT and Corporate Finance Report Summary Bata India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Acuity Brands, Inc.:戦略・SWOT・企業財務分析
    Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cogstate Ltd (CGS)-医療機器分野:企業M&A・提携分析
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • Cummins Inc.:企業の戦略・SWOT・財務情報
    Cummins Inc. - Strategy, SWOT and Corporate Finance Report Summary Cummins Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MGP Ingredients Inc (MGPI):企業の財務・戦略的SWOT分析
    MGP Ingredients Inc (MGPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alliance Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Alliance Oil Company Ltd (AOC) is an integrated oil and gas company. It explores for, extracts, and produces crude oil and gas; refines oil; and transports and sells oil products. The company has oil and gas exploration and production fields in the Timano-Pechora, Volga-Urals and Tomsk regio …
  • Ascopiave SpA (ASC):企業の財務・戦略的SWOT分析
    Ascopiave SpA (ASC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Minerals Technologies Inc (MTX):企業の財務・戦略的SWOT分析
    Minerals Technologies Inc (MTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • EFG International AG:企業の戦略・SWOT・財務情報
    EFG International AG - Strategy, SWOT and Corporate Finance Report Summary EFG International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Zealand Pharma AS (ZEAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆